BBK Worldwide Features Advarra Executive Michele Russell-Einhorn in COVID-19 Video
BBK Worldwide interviewed Michele Russell-Einhorn, Advarra Chief Compliance Officer and Institutional Official, for a special COVID-19 edition of its Pharma15 Live! Video series.
In the video, Russell-Einhorn discusses the IRB perspective on managing clinical trial enrollment and engagement modifications due to the COVID-19 pandemic. She also provides IRB insights on reimbursement, participant travel, site closures, remote consent, and other topics.
BBK Worldwide is a full-service R&D marketing firm committed to enhancing the clinical trial participant experience through a combination of services and technology-driven solutions that educate consumers, engage participants, unburden sites, and support sponsors.
For more on the research impact of COVID-19, visit Advarra’s Coronavirus Guidance webpage.